⌘K

Login Start Free

Home/Filings/4/0001415889-22-012560

4//SEC Filing

Walsh Angela 4

Accession 0001415889-22-012560

CIK 0001818844other

View on SEC.gov Company Profile

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 6:32 PM ET

Size

5.3 KB

Accession

0001415889-22-012560

Insider Transaction Report

Form 4

Period: 2022-12-12

Virios Therapeutics, Inc.VIRI

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2022-12-12+80,000→ 80,000 total
Exercise: $0.28Exp: 2032-12-12→ Common Stock (80,000 underlying)

Footnotes (1)

[F1]The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter.

Documents

1 file

4
form4-12142022_111252.xmlPrimary

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1

filerCIK 0001825987

Filing Metadata

Form type: 4
Filed: Dec 13, 7:00 PM ET
Accepted: Dec 14, 6:32 PM ET
Size: 5.3 KB

View on SEC.gov